Monday, March 18, 2024
HomeIndustriesBiotechnology

Biotechnology

X-Therma’s $22.4M Series B Sets Stage to Transform Regenerative Medicine and Organ Transplantation

Oversubscribed round propels company towards clinical trials and global market expansion, promising to extend organ preservation times and revolutionize healthcare. X-Therma Inc., a biotechnology company...

Poseida Therapeutics Announces FDA Orphan Drug Designation Granted to P-BCMA-ALLO1 for the Treatment of Multiple Myeloma

Data Describing Activity of P-BCMA-ALLO1 in BCMA-Experienced Patients to be Presented at Upcoming AACR Meeting Poseida Therapeutics, Inc., a clinical-stage cell and gene therapy company...

Biosero Appoints Daniel Schumann as Chief Operations Officer

Biosero, Inc., developer of laboratory automation solutions to orchestrate scientific discoveries, announced the appointment of Daniel Schumann to the position of chief operations officer....

MOMA Therapeutics Appoints Jullian G. Jones, Ph.D., J.D., MBA, as Chief Business Officer

MOMA Therapeutics, a biopharmaceutical company discovering and developing a new generation of precision therapeutics via insights derived from the company’s KnowledgeBase platform, announced that...

Bruker Advances CCS-Enabled 4D-Proteomics timsTOF Solutions for Immunopeptidomes and Glycoproteomics at US HUPO

At the 20th US Human Proteome Organization Congress 2024, Bruker Corporation announced progress in immunopeptidomics, glycoproteomics and other CCS-enabled 4D-proteomics workflows. The rapid advances in deep,...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics